Multidimensional effects of sertraline in social anxiety disorder

Depression and Anxiety

Volumn 23, Issue 1, 2006, Pages 6-10

  Connor, Kathryn M ^a   Davidson, Jonathan R T ^a   Chung, Henry ^b   Yang, Ruoyong ^b   Clary, Cathryn M ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b PFIZER INC   (United States)

Author keywords

Blushing; Hyperhidrosis; Phobic disorders; Randomized controlled trial; Serotonin reuptake inhibitors; Sertraline; Social anxiety disorder

Indexed keywords

CLONAZEPAM; FLUOXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; AROUSAL; ARTICLE; AVOIDANCE BEHAVIOR; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEAR; FEMALE; HEART PALPITATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONVERBAL COMMUNICATION; PRIORITY JOURNAL; SOCIAL PHOBIA; SWEATING; SYMPTOMATOLOGY; TREMOR;

ACUTE DISEASE; ADULT; DEMOGRAPHY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PHOBIC DISORDERS; QUESTIONNAIRES; SEROTONIN UPTAKE INHIBITORS; SERTRALINE;

EID: 33644557397     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.20086     Document Type: Article

References (20)

1. Altman RS, Schwartz RA. 2002. Emotionally induced hyperhidrosis. Cutis 69:336-338.
2. American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: Author.
3. Baldwin D, Bobes J, Stein DJ, Scharwachter I, Faure M. 1999. Paroxetine in social phobia/social phobia: Randomised, double-blind, placebo-controlled study: Paroxetine Study Group. Br J Psychiatry 175:120-126.
4. Davidson JR, Foa EB, Connor KM, Churchill LE. 2002. Hyperhidrosis in social anxiety disorder. Prog Neuropsychopharmacol Biol Psychiatry 26:1327-1331.
5. Davidson JR, Foa EB, Huppert JD, Keefe FJ, Franklin ME, Compton JS, Zhao N, Connor KM, Lynch TR, Gadde KM. 2004. Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia. Arch Gen Psychiatry 61:1005-1013.
6. Davidson JR, Miner CM, De Veaugh-Geiss J, Tupler LA, Colket JT, Potts NL. 1997. The Brief Social Phobia Scale: A psychometric evaluation. Psychol Med 27:161-166.
7. Drott C, Claes G, Olsson-Rex L, Dalman P, Fahlen T, Gothberg G. 1998. Successful treatment of facial blushing by endoscopic transthoracic sympathicotomy. Br J Dermatol 138:639-643.
8. Freedman RR, Blacker CM. 2002. Estrogen raises the sweating threshold in postmenopausal women with hot flashes. Fertil Steril 77:487-490.
9. Heckmann M, Ceballos-Baumann AO, Plewig G, Hyperhidrosis Study Group. 2001. Botulinum toxin A for axillary hyperhidrosis (excessive sweating). N Engl J Med 344:488-493.
10. Holzle E. 2002. Pathophysiology of sweating. Curr Probl Dermatol 30:10-22.
11. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchun HU, Kendler KS. 1994. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidiry Survey. Arch Gen Psychiatry 51:8-19.
12. Liebowitz M, DeMartinis N, Weihs K, Landbloom R, Londborg P, Smith WT, Chung H, Fayyad R, Clary CM. 2003. Efficacy of sertraline in severe generalized social anxiety disorder: Results of a double-blind placebo-controlled study. J Clin Psychiatry 64:785-792.
13. Magee WJ, Eaton WW, Wittchen HU, McGonagle KA, Kessler RC. 1996. Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey. Arch Gen Psychiatry 53:159-168.
14. Mavissakalian MR. 1996. Phenomenology of panic attacks: Responsiveness of individual symptoms to imipramine. J Clin Psychopharmacol 16:233-237.
15. Pollentier S. 1992. How erythrophobia became social phobia: An overview of the clinical-diagnostic topic. Nervenarzt 63:28-33.
16. Stein MB, Liebowitz MR, Lydiard RB, Pitts CD, Bushnell W, Gergel I. 1998. Paroxetine treatment of generalized social phobia (social anxiety disorder): A randomized controlled trial. JAMA 280:708-713.
17. Van Ameringen MA, Lane RM, Walker JR, Bowen RC, Chokka PR, Goldner EM, Johnston DG, Lavallee YJ, Nandy S, Pecknold JC, Hadrava V, Swinson RP. 2001. Sertraline treatment of generalized social phobia: A 20-week, double-blind, placebo-controlled study. Am J Psychiatry 158:275-281.
18. Van Vliet IM, den Boer JA, Westenberg HGM. 1994. Psychopharmacological treatment of social phobia: A double-blind placebo-controlled study with fluvoxamine. Psychopharmacology 115:128-134.
19. Wittchen HU, Stein MB, Kessler RC. 1999. Social fears and social phobia in a community sample of adolescents and young adults: Prevalence, risk factors and co-morbidity. Psychol Med 29:309-323.
20. Yilmaz EN, Dur AH, Cuesta MA, Rauwerda JA. 1996. Endoscopic versus transaxillary thoracic sympathectomy for primary axillary and palmar hyperhidrosis and/or facial blushing: 5-year experience. Eur J Cardiothorac Surg 10:168-172.